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Teasing Out Solid Stem Cells
Tissue stem cells can be challenging to identify, and as different groups often use distinct techniques and phenotypic markers to
isolate candidate populations, it can also be difficult to compare candidate stem cell pools described in independent studies. In
this issue, Miller and colleagues describe a connection between previously identified Sox2+ subpopulations of dermal hair follicle
progenitors and skin-derived progenitors, or SKPs. Their findings suggest that SKPs derive from the
Sox2-expressing dermal cells and have properties consistent with a dermal stem cell identity, including
participation in dermal maintenance, wound healing, and serial hair follicle morphogenesis. Identification of
stem cell populations from skin andmany other tissues depends on the ability to isolate candidate pools, often
using flow cytometric methods based on cell surface marker expression. Also in this issue, Alexander and
coauthors make suggestions for improving documentation in published accounts that use flow cytometry
to examine stem and progenitor cell activity in solid tissues and tumors. In their Forum article, the authors
emphasize that including a description of the proper controls and reporting extensive details regarding the
materials, methods, and machine parameters used in these studies would help the community by allowing
for better comparison of findings across laboratories andwould also improve the level of consistency between
published reports.
Steps toward Diseases in a Dish
Pluripotent cells and their derivatives have been hailed as a powerful system for the interrogation of human disease mechanisms for
developing candidate therapeutic interventions. The isolation of patient-derived pluripotent cells via somatic cell reprogramming
brought this paradigm of in vitro disease models even further into the limelight. In this issue, Saha and Jaenisch review not only
the research potential of this approach, but also discuss the many significant hurdles facing the application of iPSC technology to
effective disease-modeling initiatives. One of the many major challenges that remain is to develop effective protocols for differenti-
ation of the pluripotent cells to desired cell types. Kim and colleagues take a step in this direction by revealing an important autor-
egulatory signaling axis that functions during the differentiation of ESCs to dopamine (DA)-producing neurons. They demonstrate that
activation of Wnt and Shh pathways combine to trigger multiple downstream transcription factors that lead to DA-neuron production
from ESCs and during embryonic development. Improving techniques to generate large numbers of DA neurons will aid the efforts to
design faithful disease models and/or drug screening systems for Parkinson’s disease, especially if the same protocols can be used
with patient-derived iPSCs.
Something Old Needs Something New
While the physical symptoms and presentation of Alzheimer’s disease (AD) are well known, the specificmechanisms that underlie the
pathology have been more challenging to uncover. In this issue, two independent studies use distinct mouse models to identify
a common signaling pathway that may contribute to disease onset and/or progression. In one paper, Huang
and colleagues generate transgenic mice that carry human isoforms of apolipoprotein E (ApoE), one of which
is associated with higher risk for AD.Mice expressing the high-risk isoform (ApoE4) exhibited defects in hippo-
campal neurogenesis, and a loss of GABAergic interneuron input and survival. Importantly, the authors found
that potentiating GABAergic signals in thesemice could restore neurogenesis. Meanwhile, Gan and coauthors
examined neurogenesis in human amyloid precursor protein (APP) transgenic animals, which accumulate
a hallmark toxic protein (Ab) observed in AD patients. These authors also identified a role for GABAergic
signaling in the later-stage generation and maturation of adult-born hippocampal neurons, and suggest
that high levels of Ab skew the balance of GABAergic versus glutamatergic signaling to disrupt normal adult
neurogenesis in AD.
Stem Cell Networking
Cell-fate decisions result from the integration of intrinsic and extrinsic signal cascades, and new technologies have aided in connect-
ing collaborating pathways in order to define networks of signals and interacting transcription factors. In ESCs, a growing number of
pluripotency networks have been defined, and an important common feature is the central role of the transcription factor Oct4. For
murine cells, extrinsic activation of Stat3 by LIF is also an essential player in the network, and in this issue, Smith and coauthors reveal
that Oct4 and Stat3 combine to activate two related pluripotency factors, KLF2 and KLF4. They further demonstrate that KLF2 or
KLF4 expression can mitigate the requirement for LIF, revealing that these downstream components of the pluripotency network
aid inmaintaining the undifferentiated, pluripotent state. In a separate study, Enver and colleagues look at components of a regulatory
network that maintains hematopoietic stem cell function. They found that conditional deletion of the transcriptional coactivator
Cited2 led to loss of primitive HSCs and marrow failure, whereas targeting more mature lymphoid or myeloid precursors had no
functional impact on the blood system. The effects seenwith loss of Cited2 required the p16ink4a/p19ARF and p53 pathways. Impor-
tantly, this role of Cited2 is conserved in human cells, raising the possibility that further investigation of this regulatory network could
highlight potential therapeutic strategies for addressing clinical HSC defects.Cell Stem Cell 5, December 4, 2009 ª2009 Elsevier Inc. xiii
